Search filters

Filters
Clear All

Phase

  • 3
  • 1
  • 3
  • 2
  • 43
  • 52
  • 35
  • 52

Found 52 Allergy trials

A listing of Allergy medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

99 years and younger
All genders
This phase 3 study will evaluate bexotograst in patients with IPF. The study will include a CT, PEs, lung function testing, EKGs, vital signs, questionnaires, and safety labs, as well as PK and PD testing.
99 years and younger
All genders
This protocol will assess the safety and tolerability of BMS 986278 in patients with PPF. It will involve PEs, safety labs, clinical labs, pulmonary tests, EKGs, HRCTs, vital signs, and 6MWTs.
 A Clinical Study of Aliya Pulsed Electric Fields (PEF) Delivered Prior to Standard of Care Treatment of Advanced Cancer
22-100 years
All genders
Phase 4
The Investigation Device Exemption (IDE) study will evaluate the safety of delivering Aliya PEF in patients with metastatic cancer within the lungs or stage IV non-small cell lung cancer NSCLC) who are treatment-naïve and indicated for first-line standard of care (SOC) cancer therapy.
99 years and younger
All genders
See protocol section 2.1 See protocol section 2.2 See protocol section 2.3
99 years and younger
All genders
Determine safety and tolerability of IV administered doses of CMTX-101. Determine safety and tolerability of IV administered doses of CMTX-101. Assess the PK of different doses of CMTX-101. Evaluate immunogenicity (i.e., development of anti-drug antibodies [ADA] and neutralizing antibodies [Nabs]) of a single IV administered dose of CMTX-101. Assess the …
99 years and younger
All genders
This study is an exploratory, two-part, 12-week, Phase 2a study to evaluate the mechanism of action of itepekimab (anti-IL-33-mAb) and its impact on airway inflammation in former and current smokers with COPD.
99 years and younger
All genders
This is an OLE for all subjects we currently have enrolled in BI 1305-0014 and 1305-0023. Subjects will be on either 9 mg or 18 mg of IP based on results from the current studies. Procedures involve safety labs, lung function testing, clinical labs, ECGs, PEs, AE collection.
99 years and younger
All genders
The objective of this pragmatic clinical trial is to determine the real-world effect of a radiomics-based computer-aided diagnosis tool on pulmonary nodule management decisions. We hypothesize that a higher proportion of pulmonary nodules will be appropriately managed when clinicians prospectively use a CAD-based risk stratification strategy to evaluate pulmonary nodules. …
99 years and younger
All genders
This is a prospective, open-label, multi-center, single-arm study enrolling subjects with severe heterogeneous emphysema and collateral ventilation in the target lobe. Subjects will undergo instillation of AeriSeal Foam in the target lobe and subsequent assessment CV status using Chartis Pulmonary Assessment System. Subjects with CV- status will then undergo placement …
99 years and younger
All genders
PURPOSE This study will aim to (1) understand the way in which muscle loss occurs in Pulmonary Arterial Hypertension, particularly the role of fat surrounding the heart, and (2) look at the impact muscle loss has on quality of life, daily physical activity, and hospitalizations in patients with PAH. Subjects …